Write in a clean editor, then format for Clinical Sarcoma Research in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Clinical Sarcoma Research is a peer-reviewed journal published by Springer Nature, covering Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Vascular Tumors and Angiosarcomas.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Clinical Sarcoma Research 12, 45–58 (2023).
Formats any DOI in Clinical Sarcoma Research style. No sign-up. |
| Publishes research in | Sarcoma Diagnosis and Treatment Bone Tumor Diagnosis and Treatments Vascular Tumors and Angiosarcomas Gastrointestinal Tumor Research and Treatment Cardiac tumors and thrombi |
| ISSN | 2045-3329 |
| h-index | 44 |
| i10-index | 147 |
| Total citations | 7,130 |
| Open access | Yes |
| Top institutions publishing here | Leiden University Medical Center |
| Journal website | clinicalsarcomaresearch.biomedcentral.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Sarcomas account for over 20% of all pediatric solid malignant cancers and less than 1% of all adult solid malignant cancers. The vast majority of diagnosed sarcomas will be soft tissue sarcomas, while malignant bone tumors make up just over 10% of sarcomas. The risks for sarcoma are not well-understood. We evaluated the existing literature…
Soft tissue sarcomas (STS) are rare tumours arising in mesenchymal tissues, and can occur almost anywhere in the body. Their rarity, and the heterogeneity of subtype and location means that developing evidence-based guidelines is complicated by the limitations of the data available. However, this makes it more important that STS are managed by teams, expert…
This document is an update of the British Sarcoma Group guidelines published in 2010. The aim is to provide a reference standard for the clinical care of patients in the UK with bone sarcomas. Recent recommendations by the European Society of Medical Oncology, The National Comprehensive Cancer Network and The National Institute for Health and…
BACKGROUND: Manipulation of immune checkpoints such as CTLA4 or PD-1 with targeted antibodies has recently emerged as an effective anticancer strategy in multiple malignancies. Sarcomas are a heterogeneous group of diseases in need of more effective treatments. Different subtypes of soft tissue and bone sarcomas have been shown to express PD-1 ligand. METHODS: We retrospectively…
BACKGROUND: Malignant peripheral nerve sheath tumours (MPNST) are rare tumours known to occur at high frequency in neurofibromatosis 1 (NF1), but may also occur in other cancer prone syndromes. METHODS: The North West Regional Genetic Register covers a population of 4.1 million and was interrogated for incidence of MPNST in 12 cancer prone syndromes. Age,…
